Weight-loss medication and bariatric surgery are not always competing choices. Rochester-based UR Medicine specialists say some patients may use medication before surgery or afterward as part of long-term obesity treatment.
The options work differently and carry different follow-up needs, according to Wilfredo Cruz, an obesity medicine specialist, and Kaci Schiavone, a bariatric surgeon. They said a patient's health, medical history, goals and preferences should guide the decision with a care team.
How the treatments differ
GLP-1 medicines mimic hormones released after eating and can reduce hunger or help people feel full sooner and longer. UR Medicine lists semaglutide, used in Wegovy and Ozempic; tirzepatide, used in Zepbound; liraglutide, used in Saxenda; and the daily oral drug orforglipron, sold as Foundayo, among medication options discussed in its guide.
Ozempic and Wegovy contain the same active ingredient, semaglutide, but have different approved uses: Ozempic is approved for Type 2 diabetes, while Wegovy is approved for chronic weight management, the health system noted. The choice of a drug and its use should be reviewed with a clinician, rather than inferred from a shared ingredient.
Medication is usually a long-term treatment, UR Medicine said. Weight regain can follow after a patient stops taking it. Its comparison chart also notes gastrointestinal side effects and other considerations that vary by medication.
Bariatric, or metabolic, surgery changes the digestive system and hormone signals related to hunger, fullness and blood sugar. The procedures offered by UR Medicine can reduce how much the stomach holds and improve conditions such as Type 2 diabetes. Surgery involves anesthesia and recovery risks, as well as the possibility of nutritional deficiencies.
The health system says surgery generally produces greater and more durable weight loss than medication, especially for people with a body mass index above 45. Its chart lists total body weight loss of 25% to 30% after gastric sleeve surgery and 30% to 35% after gastric bypass in patients without diabetes. The medication ranges in the same chart vary by drug. Those figures are general comparisons, not predictions of an individual patient's result.
Surgery makes lasting physical changes, but patients still need nutrition support, physical activity, vitamins and regular medical follow-up, the guide says. Schiavone said medication alone may not produce enough weight loss for some patients seeking improvements in related conditions such as diabetes, high blood pressure or sleep apnea.
Why some patients use both
Doctors may consider anti-obesity medication before surgery or while a patient prepares for it. UR Medicine said losing some weight beforehand can make an operation safer and may lower complication risks. Cruz said he generally recommends trying an oral anti-obesity medication with diet and exercise before considering surgery.
Medication may also be considered after an operation if a patient loses less weight than expected, needs more help with obesity or a related condition, or begins to regain weight. Cruz said a GLP-1 or another anti-obesity medicine can be part of the response to weight regain after an initial large loss.
There is no single treatment that fits everyone, the specialists said. They suggested patients ask what results are realistic, how each option may affect other health conditions, whether long-term medication is acceptable, what risks and follow-up are involved, and whether both treatments could play a role. The answer may change over time as a patient's health and needs change.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to news@fingerlakes1.com.